These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12870023)

  • 1. [Preliminary study of HPV16 L1/E6-E7 chimeric recombinant DNA vaccine plasmid construction and expression in CHO cell].
    Zheng J; Zhang FP; Si LS; Dong XP; Wang YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):66-9. PubMed ID: 12870023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.
    Park DS; Selvey LA; Kelsall SR; Frazer IH
    J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
    Wang H; Yu JY; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins].
    Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
    Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
    Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.
    Lasaro MO; Diniz MO; Reyes-Sandoval A; Ertl HC; Ferreira LC
    Microbes Infect; 2005 Dec; 7(15):1541-50. PubMed ID: 16213178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
    Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
    Illiano E; Bissa M; Paolini F; Zanotto C; De Giuli Morghen C; Franconi R; Radaelli A; Venuti A
    Virus Res; 2016 Oct; 225():82-90. PubMed ID: 27664839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
    Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
    Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
    Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of recombinant vaccina virus of HPV16 and its antitumor effect].
    Huang W; Tian HW; Ren J; Fan JT; Zhao L; Ruan L
    Ai Zheng; 2005 Jul; 24(7):817-22. PubMed ID: 16004807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES.
    Kim SJ; Lee C; Lee SY; Kim I; Park JS; Sasagawa T; Ko JJ; Park SE; Oh YK
    Gene Ther; 2003 Aug; 10(15):1268-73. PubMed ID: 12858192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene.
    Smahel M; Sobotkova E; Vonka V; Hamsikova E; Zak R; Kitasato H; Ludvikova V
    Oncol Rep; 1999; 6(1):211-5. PubMed ID: 9864430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
    Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.
    Peng S; Ji H; Trimble C; He L; Tsai YC; Yeatermeyer J; Boyd DA; Hung CF; Wu TC
    J Virol; 2004 Aug; 78(16):8468-76. PubMed ID: 15280455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HPV16 E6 or E7 increases integration of foreign DNA.
    Kessis TD; Connolly DC; Hedrick L; Cho KR
    Oncogene; 1996 Jul; 13(2):427-31. PubMed ID: 8710383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells.
    Smahel M; Síma P; Ludvíková V; Vonka V
    Virology; 2001 Mar; 281(2):231-8. PubMed ID: 11277695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses.
    Oosterhuis K; Aleyd E; Vrijland K; Schumacher TN; Haanen JB
    Hum Gene Ther; 2012 Dec; 23(12):1301-12. PubMed ID: 22971245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.
    Daemen T; Riezebos-Brilman A; Bungener L; Regts J; Dontje B; Wilschut J
    Vaccine; 2003 Mar; 21(11-12):1082-8. PubMed ID: 12559783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.